Pathway-targeted pharmacogenomics of CYP1A2 in human liver

Pathway-targeted pharmacogenomics of CYP1A2 in human liver

The human drug metabolizing cytochrome P450 (CYP) 1A2, is one of the major P450 isoforms contributing by about 5-20% to the hepatic P450 pool and catalyzing oxidative biotransformation of up to 10% of clinically relevant drugs including clozapine and caffeine. CYP1A2 activity is interindividually hi...

Full description

Bibliographic Details
Main Authors: Kathrin eKlein, Stefan eWinter, Miia eTurpeinen, Matthias eSchwab, Ulrich M Zanger
Format: Article
Language:English
Published: Frontiers Media S.A. 2010-11-01
Series:Frontiers in Pharmacology
Subjects:
Pharmacogenetics
pharmacogenomics
SNP
cytochrome P450
multivariate analysis
candidate gene
Online Access:http://journal.frontiersin.org/Journal/10.3389/fphar.2010.00129/full

Internet

http://journal.frontiersin.org/Journal/10.3389/fphar.2010.00129/full

Similar Items